Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Farmers Insurance
Mallinckrodt
Fuji
Medtronic
Johnson and Johnson
Julphar
Moodys
Boehringer Ingelheim

Generated: August 17, 2018

DrugPatentWatch Database Preview

NAPROXEN - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for naproxen and what is the scope of naproxen patent protection?

Naproxen is the generic ingredient in twelve branded drugs marketed by Atnahs Pharma Us, West-ward Pharms Int, Actavis Elizabeth, Fosun Pharma, Invagen Pharms, Mylan Pharms Inc, Pliva, Teva, Amneal Pharms Ny, Aurobindo Pharma Ltd, Chartwell Molecules, Dava Pharms Inc, Glenmark Generics, Hamilton Pharms, Hikma Intl Pharms, Ivax Sub Teva Pharms, Marksans Pharma, Mylan, Perrigo R And D, Purepac Pharm, Roxane, Teva Pharms, Watson Labs, Watson Labs Teva, Zydus Pharms Usa, Bionpharma Inc, Puracap Pharm Llc, Alvogen Malta, Actavis Labs Fl Inc, Bayer, Able, Contract Pharmacal, Dr Reddys Labs Inc, Dr Reddys Labs Ltd, Glenmark Pharms Ltd, Granules India, Hikma, Lnk Intl Inc, Perrigo, Pld Acquisitions Llc, Sandoz, Sun Pharm Inds Ltd, and Pernix Ireland Ltd, and is included in seventy-four NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are forty-two drug master file entries for naproxen. Seventy-three suppliers are listed for this compound. There is one tentative approval for this compound.

Pharmacology for NAPROXEN
Medical Subject Heading (MeSH) Categories for NAPROXEN
Synonyms for NAPROXEN
(+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid
(+)-(S)-Naproxen
(+)-2-(6-Methoxy-2-naphthyl)propionic acid
(+)-2-(Methoxy-2-naphthyl)-propionic acid
(+)-2-(Methoxy-2-naphthyl)-propionsaeure
(+)-2-(Methoxy-2-naphthyl)-propionsaeure [German]
(+)-2-(Methoxy-2-naphthyl)-propionsaure
(+)-6-Methoxy-.alpha.-methyl-2-naphthaleneacetic acid
(+)-6-Methoxy-.alpha.-methyl-2-napthaleneacetic acid
(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid
(+)-Naproxen
(+)(S)2-(6-methoxy-2-naphthyl)-propionic acid
(+)NAPROXEN
(2S)-2-(6-methoxy-2-naphthyl)propanoic acid
(2S)-2-(6-methoxy(2-naphthyl))propanoic acid
(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid
(S)-()-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid
(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid
(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid; Naproxen
(S)-(+)-2-(6-methoxy-naphthalen-2-yl)-propionic acid
(S)-(+)-6-Methoxy-?-methyl-2-naphthalene acetic acid
(S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid
(S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid, 98%
(S)-(+)-Naproxen
(S)-(+)-Naproxene
(S)-2-(6-methoxy-2-naphthyl)-propionic acid
(S)-2-(6-Methoxy-2-naphthyl)propanoic acid
(S)-2-(6-Methoxy-2-naphthyl)propionic acid
(S)-2-(6-Methoxy-naphthalen-2-yl)-propionic acid
(S)-2-(6-methoxynaphthalen-2-yl)propanoic acid
(S)-6-Methoxy-.alpha.-methyl-2-naphthalene acetic acid
(S)-6-Methoxy-.alpha.-methyl-2-naphthaleneacetic acid
(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid
(S)-Naproxen
04N531
2-(6-Methoxy-2-naphthyl)propanoic acid , (+)-
2-(6-Methoxy-naphthalen-2-yl)-propionic acid(Naproxen)
2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (.alpha.S)-
2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (+)-
2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (S)-
2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (+)-
2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (+)- (8CI)
2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (S)-
22204-53-1
26159-31-9
4or0
4po0
57Y76R9ATQ
AB00052049_05
AB00052049-04
AB1009325
AC-1363
AC1L4G3X
AC1Q4ET9
AC1Q4F4H
AC1Q4F4I
ACT02593
Acusprain
AJ-11169
AK-72928
AKOS005267223
Aleve
AM20060551
AN-14988
Anaprox
Anax
Anexopen
ANW-24773
Apo-Napro-NA
Apo-Naproxen
Apronax
aproxen
ARONIS24306
Artagen
Arthrisil
Artrixen
Artroxen
Atiflan
Axer
BC208049
BDBM50339185
BIDD:GT0062
Bipronyl
Bonyl
BR-72928
BRD-K59197931-001-02-9
BRD-K59197931-236-09-6
BSPBio_002067
C01517
Calosen
CAS-22204-53-1
CCG-40130
CCRIS 5265
CG 3117
CHEBI:7476
CHEMBL154
Clinosyn
CMWTZPSULFXXJA-VIFPVBQESA-
CMWTZPSULFXXJA-VIFPVBQESA-N
Congex
CS-2163
CTK8B1225
d-2-(6-Methoxy-2-naphthyl)propionic acid
d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure
d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure [German]
d-Naproxen
D00118
D0DJ1B
D0S2QI
Danaprox
Daprox
DB00788
Diocodal
DivK1c_000242
DL Naproxen
DSSTox_CID_20686
DSSTox_GSID_40686
DSSTox_RID_79542
DTXSID4040686
Duk
Dysmenalgit
Dysmenalgit N
Ec-Naprosyn
EINECS 244-838-7
Epitope ID:139974
Equiproxen
Equiproxen (Veterinary)
Flanax Forte
Flexen
Flexipen
Floginax
FT-0082415
FT-0602835
Fuxen
Genoxen
GTPL5230
Headlon
HMS1920P13
HMS2089N21
HMS2091H12
HMS3649M13
HMS500M04
HSDB 3369
HY-15030
IDI1_000242
InChI=1/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1
J10145
KBio1_000242
KBio2_001457
KBio2_004025
KBio2_006593
KBio3_001567
KBioGR_000597
KBioSS_001457
KS-00002WWU
KSC911E2L
Laraflex
Laser
Lefaine
Leniartil
Lopac0_000792
LS-124738
M-5280
M1021
MCULE-2589082817
ME-0100
Methoxypropiocin
MFCD00010500
Mnpa
MolPort-000-145-960
Nafasol
Naixan
Nalyxan
Napflam
Napmel
Naposin
Napratec
Naprelan
Napren
Napren E
Naprium
Naprius
Naprolag
Naprontag
Naprosin
Naprosine
Naprosy
Naprosyn
Naprosyn (TN)
Naprosyn LLE
Naprosyn LLE Forte
Naprosyne
Naproxen (JP17/USP/INN)
Naproxen [USAN:BAN:INN:JAN]
Naproxen 1.0 mg/ml in Methanol
Naproxen solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
Naproxen, British Pharmacopoeia (BP) Reference Standard
Naproxen, European Pharmacopoeia (EP) Reference Standard
Naproxen, meets USP testing specifications
Naproxen, pharmaceutical secondary standard; traceable to USP, PhEur and BP
Naproxen, United States Pharmacopeia (USP) Reference Standard
Naproxen, VETRANAL(TM), analytical standard
naproxen(+)
Naproxen2-(6-Methoxy-naphthalen-2-yl)-propionic acid
Naproxene
Naproxene [INN-French]
Naproxeno
Naproxeno [INN-Spanish]
Naproxenum
Naproxenum [INN-Latin]
Naproxi 250
Naproxi 500
Naprux
Napxen
Narma
Narocin
Naxen
Naxen F
Naxopren
Naxyn
Naxyn 250
Naxyn 500
NCGC00016759-01
NCGC00016759-02
NCGC00016759-03
NCGC00021127-01
NCGC00161591-01
NCGC00255562-01
NINDS_000242
Noflam
Novonaprox
NPS
NSC-750183
NSC-757239
NSC750183
NSC757239
Nycopren
OR138579
Panoxen
Patxen
Pharmakon1600-01500425
Prafena
Prestwick_349
Prestwick0_000791
Prestwick1_000791
Prestwick2_000791
Prexan
Priaxen
Pronaxen
Propionic acid, 2-(6-methoxy-2-naphthyl)-, (+)-
Proxen
Proxen LE
Proxen LLE
Proxine
PubChem8102
Q-201447
Rahsen
Reuxen
Rheumaflex
Roxen
RP27889
RS 3540
RS-3540
RTR-010461
Saritilron
SBI-0050769.P004
SC-02561
SCHEMBL3046
Sinartrin
Sinton
Soproxen
SPBio_000966
SPBio_002861
Spectrum_000977
SPECTRUM1500425
Spectrum2_001043
Spectrum3_000514
Spectrum4_000069
Spectrum5_001327
SR-01000075977
SR-01000075977-10
SR-01000075977-3
ST2408284
STOCK1N-50633
Sutolin
Sutony
SY015060
TL8003659
Tohexen
Tox21_301953
Traumox
U-Ritis
UNII-57Y76R9ATQ
UPCMLD-DP001
UPCMLD-DP001:001
Velsay
Veradol
Vinsen
W4580
Xenar
Xenar-CR
ZINC105216
Tentative approvals for NAPROXEN
Applicant Application No. Strength Dosage Form
➤ Try a Free Trial➤ Try a Free Trial250MGTABLET;ORAL
➤ Try a Free Trial➤ Try a Free Trial500MGTABLET;ORAL
➤ Try a Free Trial➤ Try a Free Trial375MGTABLET;ORAL

US Patents and Regulatory Information for NAPROXEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Granules India NAPROXEN SODIUM naproxen sodium TABLET;ORAL 091353-001 Sep 20, 2011 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs NAPROXEN SODIUM naproxen sodium TABLET;ORAL 074195-002 Dec 21, 1993 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pliva NAPROXEN SODIUM naproxen sodium TABLET;ORAL 074242-002 Jun 20, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Invagen Pharms NAPROXEN naproxen TABLET, DELAYED RELEASE;ORAL 091432-001 Sep 19, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Purepac Pharm NAPROXEN SODIUM naproxen sodium TABLET;ORAL 074319-001 Mar 20, 1995 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for NAPROXEN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Atnahs Pharma Us NAPROSYN naproxen TABLET;ORAL 017581-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Atnahs Pharma Us NAPROSYN naproxen TABLET;ORAL 017581-004 Apr 15, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Atnahs Pharma Us NAPROSYN naproxen SUSPENSION;ORAL 018965-001 Mar 23, 1987 ➤ Try a Free Trial ➤ Try a Free Trial
Atnahs Pharma Us NAPROSYN naproxen TABLET;ORAL 017581-004 Apr 15, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Atnahs Pharma Us NAPROSYN naproxen TABLET;ORAL 017581-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Mallinckrodt
Moodys
Queensland Health
US Army
McKinsey
Argus Health
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.